Browse by Person

Export as [feed] Atom [feed] RSS
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 3.

Article

Burt, R.K., Tappenden, P., Balabanov, R. et al. (4 more authors) (2021) The cost effectiveness of immunoglobulin vs. hematopoietic stem cell transplantation for CIDP. Frontiers in Neurology, 12. 645263.

Burt, R.K., Tappenden, P. orcid.org/0000-0001-6612-2332, Han, X. et al. (5 more authors) (2020) Health economics and patient outcomes of hematopoietic stem cell transplantation versus disease-modifying therapies for relapsing remitting multiple sclerosis in the United States of America. Multiple Sclerosis and Related Disorders, 45. 102404. ISSN 2211-0348

Burt, R.K., Balabanov, R., Burman, J. et al. (20 more authors) (2019) Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial. Journal of the American Medical Association, 321 (2). pp. 165-174. ISSN 0098-7484

This list was generated on Sun Jan 2 00:20:02 2022 GMT.